Investing Profile

Noubar Afeyan

VC

Photo of Noubar Afeyan, Managing Partner at Flagship Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Massachusetts Institute of Technology Network
107 CONNECTIONS
McGill University Network
20 CONNECTIONS
cb
Flagship Ventures Managing Partner
40
$824M
CompanyStageDateRound SizeTotal Raised
Cellarity
Series COct 2022$120M
Series BFeb 2021$120M
$240M
Co-investors: Stephen Berenson (Flagship Pioneering)
Senda Biosciences
Series CAug 2022$120M
Series AOct 2020$88M
$210M
Co-investors: Ignacio Martinez (Flagship Ventures)
Apriori Bio
Series AJul 2022$50M
$50M
Tessera Therapeutics
Series CApr 2022$300M
$300M
Vesalius Therapeutics
Series AMar 2022$75M
$75M
Laronde
Series BAug 2021$440M
Series AMay 2021$50M
$490M
Co-investors: Avak Kahvejian (Flagship Pioneering), Diego Miralles (Flagship Pioneering)
Omega Therapeutics
Series CMar 2021$130M
$130M
Axcella
Series ENov 2018$59M
Series CMay 2015$39M
Series BDec 2013
Series AOct 2013$11M
$110M
Co-investors: Geoffrey von Maltzahn (Flagship Pioneering), David Berry (Flagship Ventures), Robert Connelly (Flagship Ventures), George M. Church (Catalio Capital)
Co-Founder Indigo2013 - Present
Chairman and Co-Founder Moderna Therapeutics2010 - Present
Chairman and Co-Founder Axcella Health2010 - Present
Founder, CEO and Senior Managing Partner Flagship Pioneering2000 - Present
Chairman and Co-Founder Joule Unlimited Technologies, Inc.2007 - 2017
Chairman and Co-Founder Ensemble Therapeutics Corporation2002 - 2016
Senior Lecturer MIT Sloan School of Management2000 - 2016
CEO and Founder PerSeptive Biosystems1989 - 2008
Chairman and Co-founder Codon Devices2004 - 2007
Co-founder Epitome Biosystems2003 - 2005
Chief Business Officer Applera Corporation1998 - 1999
Co-Founder Celera Genomics1998 - 1999
Chairman and Co-Founder Chemgenics Pharmaceuticals1995 - 1997
Massachusetts Institute of Technology PhD Biochemical Engineering
McGill University BS Chemical Engineering